Loading...
Late-stage Cancer Trials Will Delay Approvals But Hope Will Emerge
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
37.5%7D
14.5%1Y
37.5%7D
14.5%You can edit this narrative until Aug 15 10:13 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 15 10:13 PM. Then, changes will post as Updates.